IMS Health (IMS) Given Daily Media Sentiment Rating of 0.21
Media coverage about IMS Health (NYSE:IMS) has been trending somewhat positive on Tuesday, according to Accern Sentiment. The research firm identifies negative and positive media coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. IMS Health earned a media sentiment score of 0.21 on Accern’s scale. Accern also gave news headlines about the information technology services provider an impact score of 46.6552708859634 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.
Here are some of the news headlines that may have impacted Accern’s rankings:
- $14M Health Complex Coming to Pendleton (insideindianabusiness.com)
- Pharmacy Benefit Managers Are the Health Boogeyman Trump and Big Pharma Agree On (themarketmogul.com)
- IMS2018 Highlights Microwaves, Medicine and Mobility (bizjournals.com)
- IMS Maxims joins Rewired as a launch sponsor (digitalhealth.net)
IMS Health opened at $31.34 on Tuesday, Marketbeat Ratings reports. IMS Health has a 1-year low of $22.36 and a 1-year high of $31.59. The company has a debt-to-equity ratio of 2.53, a quick ratio of 1.12 and a current ratio of 1.12.
IMS Health Holdings, Inc (IMS) is an information and technology services company that provides solutions to its clients in the healthcare industry. The Company has its presence in over 100 countries. The Company’s data set contains over 10 petabytes of data and over 500 million patient records. It serves healthcare organizations and life science companies, including pharmaceutical, biotechnology, consumer health and medical device manufacturers, as well as distributors, providers, payers, government agencies, policymakers, researchers and the financial community.
Recommended Story: Short Selling – Explanation For Shorting Stocks
Receive News & Ratings for IMS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMS Health and related companies with MarketBeat.com's FREE daily email newsletter.